ICD-10 Coding for Multidrug-Resistant Organisms(A41.81, A41.81B, A41.81P)
Comprehensive guide to ICD-10 coding for multidrug-resistant organisms (MDRO), including VRE and MRSA. Learn about code sequencing, documentation requirements, and common pitfalls.
Complete code families applicable to Multidrug-Resistant Organisms
Compare key differences between these codes to ensure accurate selection
| Code | Description | When to Use | Key Documentation |
|---|---|---|---|
| A41.81 | Sepsis due to vancomycin-resistant Enterococcus | Use when sepsis is confirmed to be caused by vancomycin-resistant Enterococcus. |
|
| Z16.21 | Resistance to vancomycin | Use as a secondary code when documenting vancomycin resistance. |
|
Clinical Decision Support
Always review the patient's clinical documentation thoroughly. When in doubt, choose the more specific code and ensure documentation supports it.
Key Information
Essential facts and insights aboutMultidrug-Resistant Organisms
Alternative codes to consider when ruling out similar conditions
Documentation & Coding Risks
Avoid these common issues when documenting Multidrug-Resistant Organisms.
Using generic terms like 'resistant infection'
Impact
Clinical: May lead to inappropriate treatment plans., Regulatory: Non-compliance with documentation standards., Financial: Potential claim denials.
Mitigation
Use specific organism and resistance details, Educate staff on documentation standards
Incorrect sequencing of codes
Impact
Reimbursement: Incorrect sequencing can lead to denied claims., Compliance: Non-compliance with ICD-10 guidelines., Data Quality: Inaccurate clinical data representation.
Mitigation
Always sequence infection code before resistance code.
Code Sequencing
Impact
Incorrect sequencing of infection and resistance codes.
Mitigation
Regular training on ICD-10 guidelines.